ORCL
54
3
R
68
-4
BMY
56
-4
FRT
41
-4
GLW
46
-2
NSC
60
-2
NWS
90
26
KMX
66
2
MTCH
55
2
AKAM
56
-2
BBY
36
-5
CI
56
-3
CPB
30
-9
MTB
61
-3
HSIC
56
-3
AA
53
-3
CAT
62
-3
K
51
-2
BDX
52
-2
XYL
54
2
ORCL
54
3
R
68
-4
BMY
56
-4
FRT
41
-4
GLW
46
-2
NSC
60
-2
NWS
90
26
KMX
66
2
MTCH
55
2
AKAM
56
-2
BBY
36
-5
CI
56
-3
CPB
30
-9
MTB
61
-3
HSIC
56
-3
AA
53
-3
CAT
62
-3
K
51
-2
BDX
52
-2
XYL
54
2
Financhill
Back

Cellectis SA Vs. NovoCure Industry Stock Comparison

Buy
64

CLLS
Cellectis SA

Last Price:
1.98
Seasonality Move:
-5.55%
Buy
77

NVCR
NovoCure

Last Price:
30.52
Seasonality Move:
2.04%
Buy
64
Cellectis SA (CLLS) is a Buy

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.96. The Score for CLLS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • CLLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.96
    The current trend is relatively stagnant and CLLS is experiencing slight selling pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 50.42 Buy
Chaikin Money Flow: -5841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 2.01) Buy
Bollinger Bands (100): (1.89 - 2.25) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.01 Sell
20-day SMA: 1.93 Buy
50-day SMA: 1.95 Buy
200-day SMA: 2.32 Sell
8-day EMA: 2.01 Sell
20-day EMA: 1.96 Sell
50-day EMA: 1.98 Sell
200-day EMA: 2.22 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):